Regencell Bioscience Holdings Limited (RGC)
NASDAQ: RGC · Real-Time Price · USD
27.23
+2.16 (8.62%)
At close: Feb 6, 2026, 4:00 PM EST
27.64
+0.41 (1.51%)
After-hours: Feb 6, 2026, 7:57 PM EST

RGC Ratios and Metrics

Millions USD. Fiscal year is Jul - Jun.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Feb '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
13,4658,42644300450-
Market Cap Growth
20762.22%19171.44%-85.42%-33.42%--
Enterprise Value
13,4618,41839284452-
Last Close Price
27.2317.040.090.610.91-
PB Ratio
2770.411733.675.3225.0126.36-
P/TBV Ratio
2770.411733.675.3224.9226.39-
Debt / Equity Ratio
0.110.110.010.040.05-0.92
Quick Ratio
7.387.3841.1319.0628.420.01
Current Ratio
7.397.3941.9219.1528.460.02
Return on Equity (ROE)
-54.81%-54.81%-43.18%-41.71%-116.10%-
Return on Assets (ROA)
-33.20%-33.20%-28.11%-25.59%-51.87%-202.15%
Return on Capital Employed (ROCE)
-74.00%-74.00%-57.50%-52.20%-43.70%34.60%
Earnings Yield
-0.03%-0.04%-9.84%-1.96%-1.65%-
FCF Yield
-0.02%-0.04%-9.16%-1.66%-1.34%-
Buyback Yield / Dilution
----1.62%-28.06%-
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q